(CIDRAP News) – As researchers continue to sort out safety issues surrounding the monovalent vaccine used during the 2009 H1N1 flu pandemic, two new reports focusing mainly on an adjuvanted version suggest that immunization was safe for babies born to vaccinated pregnant women and that it was linked to a small but significant risk of Guillain-Barre syndrome (GBS) in some patients.
(CIDRAP News) Because of reports of increased fever and seizures in Australian and New Zealand children, the US government's Advisory Committee on Immunization Practices (ACIP) recommended today that a seasonal influenza vaccine made by CSL Ltd. should generally not be used in children from 6 months through 8 years old this fall and winter.
(CIDRAP News) The nation's supply of pandemic vaccine has grown to 111 million doses, enough so that the US Centers for Disease Control and Prevention (CDC) is turning part of its attention toward boosting the percentage of adults who get vaccinated.
(CIDRAP News) – A study in Australia showed that one dose of H1N1 influenza vaccine, rather than the two doses recommended in the United States, was enough to generate a probably protective immune response in children younger than 9 years.
(CIDRAP News) Despite a dip in cases, H1N1 influenza has not gone away and could resurge, making continued vaccination critical, government and private health officials said today.
Speaking on a webcast for health care providers conducted by the Department of Heath and Human Services (HHS), the experts urged healthcare workers to take the vaccine themselves and to continue to push it out to patients.